8th Annual Course 17th to 19th of April 2024 – Krakow, Poland
PROGRAM
Wednesday 17th 9.00 – 17.00
- 09.00 – 10.00 Registration and coffee
- 10.00 – 10.10 Introduction J. Ryś
- 10.10 – 11.10 Technology in immunohistochemistry. S. Nielsen
- 11.10 – 12.00 Interpretation pitfalls J. Klos
- 12.00 – 13.00 Lunch
- 13.00 – 14.15 The role of immunohistochemistry and molecular pathology in diagnosing tumors of the lower genital tract B. Davidson
- 14.15 – 15.00 Endometrial Carcinoma, What You Need to Know Now A. Malpica
- 15.00 – 15.30 Coffee
- 15.30 – 16.15 Ovarian and Fallopian Tube Tumors, Soundbites A. Malpica
- 16.15 – 17.00 Current challenges and practical aspects of the immunohistochemistry and molecular pathology of rare gynecological mesenchymal tumors (sarcomas). P. Dundr
Thursday 18th 8.30 – 17.45
- 08.30 – 09.15 Histological, immunohistochemical and molecular subtypes of TNBC. G. Cserni
- 09.15 – 10.00 HER2- high and low breast cancer. T. Tot
- 10.00 – 10.30 Coffee
- 10.30 – 11.15 Histological, immunohistochemical and molecular approach to differential diagnosis of pulmonary malignant neoplasms. A. Nicholson
- 11.15 – 12.00 IHC based predictive biomarkers for solid tumors (novel PD-L1 applications, claudin 18 and Ceacam 5). H. U. Schildhaus
- 12.00 – 12.30 Tuft cell-like carcinoma. The new kid on the block. J. Lasota
- 12.30 – 13.30 Lunch
- 13.30 – 14.15 Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. M. Miettinen
- 14.15 – 15.00 Optical Genome Mapping for comprehensive cytogenetic analysis of soft issue and bone tumours. M. Dębiec-Rychter
- 15.00 – 15.30 Coffee
- 15.30 – 16.15 Publicly available genomic datasets – an important resource for precision oncology M. Dębiec-Rychter
- 16.15 – 17.45 Consultation corner (10-12 cases) (A. Malpica, B. Davidson, M. Miettinen)
Friday 19th 8.30 – 16.15
- 08.30 – 09.15 Cancer of unknown origin. A. Bellizzi
- 09.15 – 10.00 Cancers of Unknown Primary Site: Clinical and Molecular Approach. K. Tałasiewicz
- 10.00 – 10.30 Coffee
- 10.30 – 11.15 Targeted therapies with companion diagnostics in the management of cancer patients: future perspectives. I. Ługowska
- 11.15 – 12.00 Next generation molecular board for functional precision medicine. M. Karmal
- 12.00 – 13.00 Lunch
- 13.00 – 13.45 Immunohistochemical detection of predictive biomarkers for molecularly targeted therapies and immunotherapies. J. Lasota
- 13.45 – 14.30 Immunohistochemistry of Head and Neck tumors. A. Bellizzi
- 14.30 – 15.00 Coffee
- 15.00 – 15.30 AI and Digital Pathology. K. Korski
- 15.30 – 16.00 Digital analysis of predictive factors in breast cancer. A. Kowalewski
- 16.00 – 16.15 Summary and conclusions. J. Ryś